XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Sep. 30, 2020   31,012    
Beginning balance at Sep. 30, 2020 $ 593,171 $ 31 $ 856,466 $ (263,326)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 73,660     73,660
Net comprehensive income 73,660     73,660
Stock-based compensation expense 9,254   9,254  
Exercises of stock options (in shares)   198    
Stock option exercises 564   564  
Shares issued under employee stock plans, net (in shares)   417    
Forfeiture and other settlements of restricted stock (in shares)   (29)    
Forfeiture and other settlements of restricted stock 0   0  
Common stock redeemed for tax liability (in shares)   (304)    
Common stock redeemed for tax liability (3,044)   (3,044)  
Ending balance (in shares) at Jun. 30, 2021   31,294    
Ending balance at Jun. 30, 2021 673,605 $ 31 863,240 (189,666)
Beginning balance (in shares) at Mar. 31, 2021   31,289    
Beginning balance at Mar. 31, 2021 633,767 $ 31 860,537 (226,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 37,135     37,135
Net comprehensive income 37,135     37,135
Stock-based compensation expense 3,194   3,194  
Exercises of stock options (in shares)   30    
Stock option exercises (67)   (67)  
Shares issued under employee stock plans, net (in shares)   6    
Forfeiture and other settlements of restricted stock (in shares)   (13)    
Common stock redeemed for tax liability (in shares)   (18)    
Common stock redeemed for tax liability (424)   (424)  
Ending balance (in shares) at Jun. 30, 2021   31,294    
Ending balance at Jun. 30, 2021 673,605 $ 31 863,240 (189,666)
Beginning balance (in shares) at Sep. 30, 2021   31,294    
Beginning balance at Sep. 30, 2021 724,884 $ 31 866,158 (141,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 133,881     133,881
Net comprehensive income 133,881     133,881
Stock-based compensation expense 6,515   6,515  
Exercises of stock options (in shares)   1    
Stock option exercises 5   5  
Shares issued under employee stock plans, net (in shares)   518    
Forfeiture and other settlements of restricted stock (in shares)   (55)    
Forfeiture and other settlements of restricted stock 0      
Common stock redeemed for tax liability (in shares)   (308)    
Common stock redeemed for tax liability (6,631)   (6,631)  
Share repurchases (in shares)   (175)    
Share repurchases (2,527)   (2,527)  
Ending balance (in shares) at Jun. 30, 2022   31,275    
Ending balance at Jun. 30, 2022 856,127 $ 31 863,520 (7,424)
Beginning balance (in shares) at Mar. 31, 2022   31,458    
Beginning balance at Mar. 31, 2022 802,357 $ 31 864,074 (61,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 54,324     54,324
Net comprehensive income 54,324     54,324
Stock-based compensation expense 1,983   1,983  
Exercises of stock options (in shares)   0    
Stock option exercises 1   1  
Shares issued under employee stock plans, net (in shares)   1    
Forfeiture and other settlements of restricted stock (in shares)   (8)    
Forfeiture and other settlements of restricted stock 0      
Common stock redeemed for tax liability (in shares)   (1)    
Common stock redeemed for tax liability (11)   (11)  
Share repurchases (in shares)   (175)    
Share repurchases (2,527)   (2,527)  
Ending balance (in shares) at Jun. 30, 2022   31,275    
Ending balance at Jun. 30, 2022 $ 856,127 $ 31 $ 863,520 $ (7,424)